Cytosurge AG
Peter van Mil is an experienced R&D Engineer currently employed at Cytosurge AG since November 2021. Prior to this role, Peter served as a Project Engineer in R&D at Codan Argus, where responsibilities included product support, industrialization, and development of volumetric and syringe infusion pumps. Invenitec AG benefited from Peter's expertise in the medical device sector, focusing on the development of surgical instruments and viscosity sensors from November 2013 to July 2016. Academic contributions include a master's thesis on an Intra-Aortic Balloon Pump and an internship developing a dynamic model for a Left Ventricle Assist Device at Eindhoven University of Technology. Peter's academic background includes dual master's degrees in Medical Engineering and Mechanical Engineering, complemented by a bachelor's degree in Mechanical Engineering and pre-university education from College Rolduc Kerkrade.
Cytosurge AG
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting-edge solutions based on its patented FluidFM® technology. At the heart of this technology are the hollow FluidFM Probes – the Micropipette, Nanopipette, and the Nanosyringe – specifically designed to offer a wide range of unique applications for single-cell manipulation in biology research. Cytosurge's current systems compatible with FluidFM probes include the FluidFM ADD-ON for AFM systems and the standalone semi-automated FluidFM OMNIUM system. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, contributing to human well-being through advancements in single-cell technologies. As the partner of choice for precision gene engineering cell line manufacturing, Cytosurge enables next-generation biologic production and cell and gene therapy treatments, empowering people to live longer and healthier lives. Cytosurge implements advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and the manufacturing of high-precision gene-engineered cell lines. With a unique single-cell workflow and dynamic gene expression analytics, Cytosurge manufactures advanced gene-engineered cell lines, empowering next-generation treatments to benefit human well-being.